PURE Bioscience
Chemicals & Related Products · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9669 Hermosa Ave, Rancho Cucamonga, Cali...Phone Number
(619) 596-8600Website
www.purebio.comRevenue
<$5 MillionStock Symbol
PUREIndustry
About PURE Bioscience
PURE Bioscience Org Chart
Is PURE Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if PURE Bioscience had a recent Job posting/layoffs
Check if PURE Bioscience has recently received funding, and reach out quickly before it becomes old news!
Check out if PURE Bioscience is spiking on competitors!
Product Launch: Get notified when PURE Bioscience launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on PURE Bioscience recently announced quarterly report
PURE Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at PURE Bioscience
Funding: Get notified immidiatlly once PURE Bioscience has new funding data
Recommended Actions
Reach out to Masked Content who joined PURE Bioscience as Masked Content
Find 3 more new buyers
Compare Similar Companies to PURE Bioscience
Compare insights from companies similar to PURE Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PURE Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PURE Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PURE Bioscience.
PURE Bioscience financials insights
Gather financial insights about PURE Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Stock Offering
$10.2M
PURE Bioscience Tech Stack
A closer look at the technologies used by PURE Bioscience
Most Recent Scoops
PURE Bioscience News & Media
PURE Bioscience Reports Fiscal Third Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2025. Summary of Results of Operations – Fiscal Third Quarter Net product sales were $489,000 and $440,000 for the fiscal third quarter ended April 30, 2025 and 2024, respectively. The increase of $49,000 was attributablPURE Bioscience Unveils Revolutionary Membrane Treatment Solution for the Dairy and Beverage Industry
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is proud to announce an innovative application method for membrane treatment in the dairy and beverage industry using our flagship product, PURE® Hard Surface. This groundbreaking solution addresses common membrane fouling and sanitization challenges, delivering outstanding results that enable opePURE Bioscience Reports Fiscal Second Quarter 2025 Financial Results
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal second quarter ended January 31, 2025. Summary of Results – Fiscal Second Quarter Operations Net product sales were $391,000 and $325,000 for the fiscal second quarter ended January 31, 2025 and 2024, respectively. The increase of $66,000 was attribuPURE Bioscience Announces a New Distribution Agreement With Hydrite Chemical Company
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Hydrite Chemical Company (“Hydrite”) have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to announce the signing of a strategic distribution agreement with Hydrite, a top-tier provider of complet
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PURE Bioscience
PURE is focused on developing and commercializing the company's proprietary antimicrobial products primarily in the food safety arena. The company provides solutions to combat the health and environmental challenges of pathogen and hygienic control. The company's technology platform is based on patented, stabilized ionic silver, and the company's i... Read More
